Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • Strategic Alliances
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Overview
    • Probuphine
    • Ropinirole Implant
    • T3 Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Provides Update On Parkinson's Disease Clinical Development Program

July 2, 2018

Titan Pharmaceuticals And Braeburn Announce Mutual Termination Of License Agreement For Probuphine® For Opioid Dependence

May 30, 2018

Titan Pharmaceuticals Reports First Quarter 2018 Financial Results

May 15, 2018

Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board

May 14, 2018

Titan Pharmaceuticals To Report First Quarter 2018 Financial Results On May 15, 2018

May 8, 2018

Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results

April 2, 2018

Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2017 Financial Results

March 26, 2018

Titan Executes Agreement For Acquisition By Molteni Of Probuphine® In Europe And Other Select Territories

March 21, 2018

Titan Announces Amendment To Horizon Loan Agreement

February 2, 2018

Titan In Discussions With Braeburn Regarding U.S. Probuphine® Commercialization

January 22, 2018

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...18
  • Next »
© 2019 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap